All News

Novavax COVID-19 Vaccine Candidate Reports 'Strong' Protection Against SARS-CoV-2, Two Variants
Ref: Fidelity
Tags: NewsPointsNovavaxCOVID-19 Immunisation Clinical Research (R&D) Medical AffairsNVX-CoV2373
Argentina issues emergency approval to China's single-dose Cansino COVID-19 vaccine
Ref: Yahoo Finance
Tags: NewsPointsAstraZeneca CanSino Biologics SinoPharmCOVID-19 Immunisation Marketing & Sales Regulatory AffairsSputnik V
Ocean Biomedical, Inc. Files Registration Statement For Proposed Initial Public Offering
Ref: GlobeNewswire
Tags: Press ReleaseOcean Biomedical Corporate Affairs
Biopharmaceutical industry welcomes COVID-19 vaccine-sharing pledges but warn challenges remain to urgently address vaccine inequity
Ref: IFPMA
Tags: Press ReleaseImmunisation COVID-19 IFPMA WHOMedical Affairs Marketing & Sales
Biogen stock heads for biggest weekly rally in more than 2 decades, UBS analyst targets more gains
Ref: MarketWatch
Tags: NewsPointsBiogen Corporate Affairs
Novavax Announces Positive Data from Three Complementary Studies of COVID-19 Beta (B.1.351) Variant Strain Vaccine
Ref: PR Newswire
Tags: Press ReleaseNovavaxCOVID-19 Immunisation Clinical Research (R&D) Medical AffairsNVX-CoV2373
Sorrento Receives Authorization From the UK Regulatory Agency to Conduct a Phase 2 Clinical Trial for COVI-DROPS in an Outpatient Setting
Ref: GlobeNewswire
Tags: Press ReleaseSorrentoCOVID-19 MHRARegulatory Affairs Clinical Research (R&D)COVI-DROPS
CSIR-IICT and SUVEN Pharmaceuticals Ltd., joined hands for the process technology transfer and manufacture of anti COVID drugs Molnupiravir and 2-DG
Ref: Suven Pharmaceuticals
Tags: Press ReleaseSuvenCOVID-19 Corporate Affairs Licensing2-DG molnupiravir
COVID-19 vaccine for young people aged 12 to 17: Moderna submits authorisation application to Swissmedic
Ref: Swissmedic
Tags: Press ReleaseModernaSwitzerlandCOVID-19 Immunisation Regulatory Affairs
Biosimilar User Fee Amendments
Ref: FDA
Tags: Press ReleaseUnited States FDARegulatory Affairs